WO1990012807A3 - Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes - Google Patents

Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes Download PDF

Info

Publication number
WO1990012807A3
WO1990012807A3 PCT/US1990/002017 US9002017W WO9012807A3 WO 1990012807 A3 WO1990012807 A3 WO 1990012807A3 US 9002017 W US9002017 W US 9002017W WO 9012807 A3 WO9012807 A3 WO 9012807A3
Authority
WO
WIPO (PCT)
Prior art keywords
purified
highly specific
gene products
antibodies against
specific antibodies
Prior art date
Application number
PCT/US1990/002017
Other languages
English (en)
Other versions
WO1990012807A2 (fr
Inventor
Hong-Ji Xu
William F Benedict
Shi-Xue Hu
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Priority to EP90911368A priority Critical patent/EP0467998B1/fr
Priority to DE69012989T priority patent/DE69012989D1/de
Publication of WO1990012807A2 publication Critical patent/WO1990012807A2/fr
Publication of WO1990012807A3 publication Critical patent/WO1990012807A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un procédé permet d'identifier les épitopes de produits génétiques, spécifiquement le gène du rétinoblastome humain (Rb) et les polypeptides antigéniques correspondants. La séquence d'acides aminés présente une combinaison de faible solubilité et d'hydrophilie élevée. On a purifié par les techniques décrites des IgG anti-Rb à affinité et à spécificité élevées. On a utilisé ces IgG anti-Rb afin de précipiter immunologiquement et de produire des schémas de Western Blot associés à des protéines de Rb normales et anormales. Ce procédé et ces produits peuvent être utilisés dans différentes démarches diagnostiques.
PCT/US1990/002017 1989-04-14 1990-04-13 Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes WO1990012807A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP90911368A EP0467998B1 (fr) 1989-04-14 1990-04-13 Peptides de produits de gene de retinblastomes et anticorps contre ceux-ci
DE69012989T DE69012989D1 (de) 1989-04-14 1990-04-13 Peptiden von retinblastoma gen produkten und antikoerper dagegen.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33828989A 1989-04-14 1989-04-14
US338,289 1989-04-14
US50805190A 1990-04-11 1990-04-11
US508,051 1990-04-11

Publications (2)

Publication Number Publication Date
WO1990012807A2 WO1990012807A2 (fr) 1990-11-01
WO1990012807A3 true WO1990012807A3 (fr) 1991-01-10

Family

ID=26991124

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/002017 WO1990012807A2 (fr) 1989-04-14 1990-04-13 Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes

Country Status (7)

Country Link
EP (1) EP0467998B1 (fr)
JP (1) JPH04504727A (fr)
AT (1) ATE112290T1 (fr)
AU (1) AU637388B2 (fr)
CA (1) CA2014473A1 (fr)
DE (1) DE69012989D1 (fr)
WO (1) WO1990012807A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651152B2 (en) * 1990-08-29 1994-07-14 Genetics Institute, Llc Multidomain hematopoiesis stimulators
US5710255A (en) * 1992-07-14 1998-01-20 Canji, Inc. Characterization of a novel anti-p110RB monoclonal antibody
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006940A1 (fr) * 1986-05-06 1987-11-19 The Regents Of The University Of California ANALYSES ET ANTICORPS DES PROTEINES N-myc
EP0259031B1 (fr) * 1986-08-11 1994-11-09 MASSACHUSETTS EYE & EAR INFIRMARY ADM humain pour le diganostic du rétinoblastome

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006940A1 (fr) * 1986-05-06 1987-11-19 The Regents Of The University Of California ANALYSES ET ANTICORPS DES PROTEINES N-myc
EP0259031B1 (fr) * 1986-08-11 1994-11-09 MASSACHUSETTS EYE & EAR INFIRMARY ADM humain pour le diganostic du rétinoblastome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Oncogene Research, Volume 1, 1989, Harwood Academic Publischers GmbH, (GB), J-Y. SHEW et al.: "Antibodies Detecting Abnormalities of the Retinoblastoma Susceptibillity Gene Product (pp110RB) in Osteosarcomas ans Synovial Sarcomas", pages 205-214 see page 206, figure 1, peptide C *

Also Published As

Publication number Publication date
DE69012989D1 (de) 1994-11-03
AU6049490A (en) 1990-11-16
AU637388B2 (en) 1993-05-27
EP0467998B1 (fr) 1994-09-28
JPH04504727A (ja) 1992-08-20
EP0467998A1 (fr) 1992-01-29
ATE112290T1 (de) 1994-10-15
CA2014473A1 (fr) 1990-10-14
WO1990012807A2 (fr) 1990-11-01

Similar Documents

Publication Publication Date Title
EP0175360A3 (fr) Anticorps contre les peptides et leurs utilisation dans la détection des produits d'oncogènes
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
CA2025598A1 (fr) Proteines d'antigene nucleocapsidique d'hepadnavirus chimerique
EP0370458A3 (fr) Antigènes à partir d'ADN synthétique dérivé du virus de l'immunodéficience humaine (HIV-1) recombinant
EP0256092A4 (fr) Virus herpetiques attenues, virus herpetiques comprenant de l'adn etranger contenant une sequence d'acide amine et vaccin les contenant.
DE3572179D1 (en) Blood coagulation inhibiting proteins, process for preparing them and their use
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
CA2042016A1 (fr) Peptides et polypeptides recombinants, acides nucleiques codant pour ceux-ci et utilisation de ces peptides et polypeptides dans le diagnostic de la tuberculose
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
GR3029264T3 (en) Anti-feline immunodeficiency virus (fiv) vaccines.
EP0306219A3 (fr) Protéines et peptides du HIV pour le diagnostic, la prophylaxie et la thérapie du SIDA
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
EP0095873A3 (en) Region-specific determinants for vitamin k dependent bone protein
MY103362A (en) Production of proteins in active forms
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
EP0177814A3 (fr) Anticorps contre les peptides et leurs utilisation dans la détection des produits d'oncogènes
WO1990012807A3 (fr) Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes
CA2058958A1 (fr) Methode pour epurer les proteines
EP0293079A3 (fr) Vaccin contre chlamydia
WO1997039029A3 (fr) Epitope antigenique du determinant a de l'antigene de surface de l'hepatite b et ses utilisations
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
EP0440207A3 (en) Expression of hiv1 and hiv2 polypeptides and use thereof
EP0293827A3 (fr) Essai pour leishmaniose
EP0317279A3 (fr) Peptides pour l'usage dans la purification du facteur-VIII

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1990911368

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1990911368

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1990911368

Country of ref document: EP